Wegovy
- Concomitant use of Wegovy (semaglutide) tablets or Wegovy (semaglutide) injection with other semaglutide-containing products or with any other GLP-1 receptor agonist is not recommended.
Label revised Jun 18, 2026. DailyMed
From each FDA label
Can you take two GLP-1s together?
6 of the 10 current GLP-1 labels say something on taking two GLP-1s together.
Read from each manufacturer's FDA label on DailyMed. The newest revision saying anything on this is Aug 28, 2026.
Word for word
What each label says about taking two GLP-1s together
Sentences from each label, in its own words. Only cross-references are removed.
Zepbound
- Coadministration with other tirzepatide-containing products or with any glucagon-like peptide-1 (GLP-1) receptor agonist is not recommended.
Label revised Aug 28, 2026. DailyMed
Foundayo
- Concomitant use with another GLP-1 receptor agonist is not recommended.
Label revised Jul 29, 2026. DailyMed
Saxenda
- Coadministration with other liraglutide-containing products or with any other glucagon-like peptide-1 (GLP-1) receptor agonist is not recommended.
Label revised Feb 25, 2026. DailyMed
Victoza
- Coadministration with other liraglutide-containing products is not recommended.
Label revised Oct 14, 2025. DailyMed
Byetta
- Coadministration with other exenatide-containing products is not recommended.
Label revised Sep 2, 2025. DailyMed
Ozempic, Rybelsus and Ozempic tablets, Mounjaro, Trulicity: no finding on this in the sections read here.
Updated automatically
Latest FDA label updates
- FDA labelFDA label updated: Zepbound (Eli Lilly and Company), effective 2026-08-28
- FDA labelFDA label updated: Mounjaro (Eli Lilly and Company), effective 2026-08-27
- FDA labelFDA label updated: Foundayo (Eli Lilly and Company), effective 2026-07-29
- FDA labelFDA label updated: Liraglutide (Meitheal Pharmaceuticals Inc.), effective 2026-07-27
- FDA labelFDA label updated: Liraglutide (NorthStar Rx LLC), effective 2026-06-24
Written from each source's own record as it changes. Every change on GLPcompare
Questions
Taking two GLP-1s on a GLP-1: common questions
Can you take two GLP-1s together?
Its FDA label: Concomitant use of Wegovy (semaglutide) tablets or Wegovy (semaglutide) injection with other semaglutide-containing products or with any other GLP-1 receptor agonist is not recommended.
Can you take two GLP-1s together?
Its FDA label: Coadministration with other tirzepatide-containing products or with any glucagon-like peptide-1 (GLP-1) receptor agonist is not recommended.
Can you take two GLP-1s together?
Its FDA label: Concomitant use with another GLP-1 receptor agonist is not recommended.
Can you take two GLP-1s together?
Its FDA label: Coadministration with other liraglutide-containing products or with any other glucagon-like peptide-1 (GLP-1) receptor agonist is not recommended.
Can you take two GLP-1s together?
Its FDA label: Coadministration with other liraglutide-containing products is not recommended.
Other side effects
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Stomach pain
- Indigestion
- Acid reflux
- Burping
- Gas
- Bloating
- Fatigue
- Headache
- Dizziness
- Hair loss
- Injection site reactions
- Skin sensitivity and tingling
- Taste changes
- Muscle loss
- Joint pain
- Insomnia
- Kidney stones
- Rash and itching
- Low blood pressure
- Anxiety
- Bone loss
- UTIs and yeast infections
- Jaw pain and clenching
- Body aches
- Pancreatitis
- Gallbladder problems
- Low blood sugar
- Kidney problems
- Gastroparesis and severe stomach problems
- Allergic reactions
- Thyroid cancer
- Eye problems
- Fast heart rate
- Aspiration under anesthesia
- Depression and suicidal thoughts
- Birth control
- Drug interactions
- Metformin
- Pregnancy
- Breastfeeding
Trial rates describe groups, not what one person will feel. Talk to your clinician before starting, stopping or changing a medicine.
GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.